Tanaka Capital Management Inc Corcept Therapeutics Inc Transaction History

Tanaka Capital Management Inc

  • $42.2 Million
  • Q2 2024

A detailed history of Tanaka Capital Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Tanaka Capital Management Inc holds 100,276 shares of CORT stock, worth $5.44 Million. This represents 7.71% of its overall portfolio holdings.

Number of Shares
100,276
Previous 90,876 10.34%
Holding current value
$5.44 Million
Previous $2.29 Million 42.33%
% of portfolio
7.71%
Previous 5.63%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$22.21 - $34.48 $208,774 - $324,111
9,400 Added 10.34%
100,276 $3.26 Million
Q1 2024

May 15, 2024
BUY
$21.1 - $27.46 $1.13 Million - $1.48 Million
53,785 Added 145.01%
90,876 $2.29 Million
Q4 2023

Feb 14, 2024
SELL
$24.82 - $32.88 $11,863 - $15,716
-478 Reduced 1.27%
37,091 $1.21 Million
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $44,599 - $68,614
2,030 Added 5.71%
37,569 $1.02 Million
Q2 2022

Aug 15, 2022
SELL
$17.33 - $25.3 $64,987 - $94,875
-3,750 Reduced 9.54%
35,539 $845,000
Q1 2022

May 16, 2022
SELL
$16.53 - $25.21 $3,801 - $5,798
-230 Reduced 0.58%
39,289 $885,000
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $8,977 - $12,253
-525 Reduced 1.31%
39,519 $782,000
Q1 2021

May 17, 2021
SELL
$23.49 - $30.56 $2,583 - $3,361
-110 Reduced 0.27%
40,044 $953,000
Q4 2020

Feb 11, 2021
SELL
$16.78 - $27.3 $2,684 - $4,368
-160 Reduced 0.4%
40,154 $1.05 Million
Q3 2020

Nov 13, 2020
SELL
$12.46 - $19.98 $268,388 - $430,369
-21,540 Reduced 34.82%
40,314 $702,000
Q2 2020

Aug 17, 2020
SELL
$11.0 - $18.26 $41,305 - $68,566
-3,755 Reduced 5.72%
61,854 $1.04 Million
Q1 2020

May 15, 2020
SELL
$10.11 - $14.04 $40,844 - $56,721
-4,040 Reduced 5.8%
65,609 $780,000
Q4 2019

Feb 14, 2020
SELL
$12.06 - $16.96 $54,149 - $76,150
-4,490 Reduced 6.06%
69,649 $843,000
Q3 2019

Nov 15, 2019
SELL
$10.41 - $14.66 $27,950 - $39,362
-2,685 Reduced 3.5%
74,139 $1.05 Million
Q2 2019

Aug 15, 2019
SELL
$9.78 - $12.76 $26,895 - $35,090
-2,750 Reduced 3.46%
76,824 $857,000
Q1 2019

May 16, 2019
SELL
$10.03 - $15.71 $84,552 - $132,435
-8,430 Reduced 9.58%
79,574 $934,000
Q4 2018

Feb 14, 2019
SELL
$11.29 - $17.19 $1,693 - $2,578
-150 Reduced 0.17%
88,004 $1.18 Million
Q2 2018

Aug 16, 2018
SELL
$15.3 - $19.69 $863,654 - $1.11 Million
-56,448 Reduced 39.04%
88,154 $1.39 Million
Q1 2018

May 15, 2018
BUY
$14.59 - $25.5 $63,028 - $110,160
4,320 Added 3.08%
144,602 $2.38 Million
Q4 2017

Feb 16, 2018
BUY
$15.77 - $20.72 $6,544 - $8,598
415 Added 0.3%
140,282 $2.53 Million
Q3 2017

Nov 16, 2017
BUY
$12.3 - $19.3 $1.72 Million - $2.7 Million
139,867
139,867 $2.7 Million

Others Institutions Holding CORT

# of Institutions
318
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.81B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Tanaka Capital Management Inc Portfolio

Follow Tanaka Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tanaka Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tanaka Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email